机译:Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Department of Medical Oncology Dana-Farber Cancer Institute and Brigham and Women's Hospital;
Cliniques universitaires Saint Luc;
Masonic Cancer Center University of MinnesotaDepartment of Genitourinary Medical Oncology The University of Texas MD Anderson Cancer CenterDuke Cancer Institute Center for Prostate and Urologic CancersUniversity College London Cancer InstituteKnight Cancer Institute Oregon Health & Science UniversityDana-Farber Cancer Institute and Brigham and Women's Hospital Harvard Medical SchoolDepartment of Urology Sk?ne University HospitalDépartement de Radiothérapie Gustave Roussy Université Paris-SaclayUnit of Urology/Division of Oncology URI IRCCS Ospedale San Raffaele Vita-Salute San RaffaeleDivision of Cancer Sciences Faculty of Biology Medicine and Health University of ManchesterDivision of Urology Department of Surgery American University of Beirut Medical CenterDepartment of Medical Oncology Santa Chiara HospitalMedical Oncology Hospital UniversitarioInstitute of Biomedical Research in Málaga (IBIMA)Fred Hutchinson Cancer Center University of WashingtonBC Cancer Vancouver Prostate Centre University of British ColumbiaGuys and St Thomas's NHS Foundation TrustResearch Department of Primary Care & Population Health Royal Free Campus University College LondonThe Christie and Salford Royal HospitalsDepartment of Oncology Copenhagen University HospitalDepartment of Urology Charité Universit?tsmedizinDepartment of Medical Oncology Hospital Universitario Marques de Valdecilla IDIVALThe Institute of Cancer Research and Royal Marsden NHS Foundation TrustHouston Methodist Cancer CenterDepartment of Radiation Oncology Hospital Universitario de La Princesa Health Research InstituteRadiation Oncology Oncology Institute of Southern Switzerland EOCOnkozentrum Zurich and University of ZurichOncology Institute of Southern Switzerland EOCGenitourinary Oncology Prostate Brachytherapy UnitMonash University and Eastern HealthThe Institute of Cancer ResearchInstitut Gustave Roussy University of Paris SaclayUniversity Jean MonnetCarolina Urologic Research CenterUCSF Helen Diller Family Comprehensive Cancer Center University of California San FranciscoMassachusetts General Hospital Cancer CenterDepartment of Radiation Oncology Massachusetts General HospitalDepartment of Surgery University of Port Harcourt Teaching HospitalUniversity of California Davis School of MedicineIRCCS Azienda Ospedaliero-Universitaria di BolognaUniversity of California San FranciscoDepartment of Radiation-Oncology Ghent University HospitalDepartment of Urology Ospedale Regionale di Lugano Civico USI - Università della Svizzera ItalianaDepartment of Surgery Prostate Cancer Research Program Monash UniversityDepartment of Medicine Duke Cancer Institute Duke UniversityUrological Sciences Vancouver Prostate Centre University of British ColumbiaDepartment of Medical Oncology Institut Paoli Calmettes Aix-Marseille UniversitéDepartment of Biostatistics and Bioinformatics Duke UniversityDepartment of Oncology and Radiotherapy Innlandet Hospital TrustDepartment of Nuclear Medicine University of Duisburg-Essen and German Cancer Consortium (DKTKUniversity of British ColumbiaProstate Cancer Theranostics and Imaging Centre of Excellence Department of Molecular Imaging andChris O'Brien LifehouseRobert H. Lurie Comprehensive Cancer Center Northwestern UniversityDepartment of Oncology and Hemato-Oncology University of MilanSchool of Cancer Sciences University of GlasgowDivision of Medical Oncology National Cancer CentreFaculty of Medicine and Health Technology Tampere University and Tampere Cancer CenterDepartment of Urology and the Naef K. Basile Cancer Institute (NKBCI) American University of BeirutDivision of Urology Sunnybrook Health Sciences Centre University of TorontoDepartment of Urology Medical University of ViennaOncology Institute Shamir Medical CenterDepartment of Radiation Oncology University of Miami Sylvester Cancer CenterBeneficiência Portuguesa de S?o PauloDepartment of Medical Oncology and Prostate Cancer Translational Research Group Vall d'HebronFaculty of Education Health and WellbeingDepartment of Medical Oncology Radboud University Medical CenterDepartment of Urology University Hospital Schleswig-HolsteinGenitourinary Oncology Service Department of Medicine Memorial Sloan Kettering Cancer CenterNational Institute of Oncology Mohamed V UniversityClemenceau Medical CenterDivision of Cancer SurgeryTata Memorial CentreDepartment of Radiation Oncology Brigham and Women's Hospital and Dana Farber Cancer InstituteDivision of Hematology and Medical Oncology Icahn School of Medicine at Mount Sinai The TischDepartment of Radiation Oncology Iridium NetwerkPatrick G Johnston Centre for Cancer Research Queen's University Belfast Northern Ireland CancerMount Vernon Cancer Centre and Institute of Cancer ResearchSheffield Teaching Hospitals NHS Foundation TrustComprehensive Oncology Centre Hong Kong Sanatorium & HospitalDepartment of Laboratory Medicine and Pathology University of WashingtonCancer Research Chair and Department of Surgery College of Medicine King Saud UniversityUniversity of California Los AngelesBern Center for Precision Medicine and Department for Biomedical ResearchCentre Hospitalier de Université de MontréalInstituto Alexander FlemingTulane Cancer CenterDepartment of Hematology and Oncology Cleveland Clinic Taussig Cancer InstituteRafal Masztak Grochowski Hospital Maria Sklodowska Curie National Research Institute of OncologyProstate Cancer FoundationUniversity Hospitals Seidman Cancer CenterDivision of Medical Oncology Stanford University Medical CenterEnglander Institute for Precision Medicine Weill Cornell Medicine Division of Hematology andMartini-Klinik Prostate Cancer Center University Hospital Hamburg-EppendorfToho University Sakura Medical CenterMRC Clinical Trials Unit at UCL Institute of Clinical Trials and Methodology University CollegeDepartment of Urology M.A. Ayd?nlar Ac?badem University Altunizade HospitalDepartment of Urology Kindai University Faculty of MedicineDepartment of Medical Oncology Ankara University School of MedicineUniversity College London MRC Clinical Trials Unit at UCLRadboud University Medical CenterDepartment of Radiation Oncology Abramson Cancer Center University of PennsylvaniaDepartment of Urology Institut Paoli-Calmettes Cancer CentreDepartment of Radiation Oncology & Cancer Epidemiology H. Lee Moffitt Cancer Center & ResearchDepartment of Urology Fudan University Shanghai Cancer CenterDepartment of Medicine Division of Oncology University of Washington and Fred Hutchinson Cancer;
Adjuvant therapy; Biochemical recurrence; Hormonal treatment; Locally advanced prostate cancer; Next-generation imaging; Prostate cancer; Prostate-specific membrane antigen positron emission tomography imaging; Salvage radiation therapy; Salvage therapy; Side effects;